NCT07428616
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07428616
Title A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma (STELLAR-201)
Acronym STELLAR-201
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Exelixis
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama RECRUITING Birmingham Alabama 35294 United States Details
Mayo Clinic_Arizona RECRUITING Phoenix Arizona 85054 United States Details
Mayo Clinic_Jacksonville RECRUITING Jacksonville Florida 32224 United States Details
Baptist Health Miami Cancer Institute RECRUITING Miami Florida 33176 United States Details
Washington University School of Medicine RECRUITING St Louis Missouri 63110 United States Details
Memorial Sloan-Kettering Cancer Center RECRUITING New York New York 10065 United States Details
Mayo Clinic_Rochester RECRUITING Rochester New York 55905 United States Details
Duke University RECRUITING Durham North Carolina 27710 United States Details
UT MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
UT Health San Antonio Mays Cancer Center RECRUITING San Antonio Texas 78229 United States Details
Inova Center for Personalized Health RECRUITING Fairfax Virginia 22031 United States Details
UW Carbone Cancer Center RECRUITING Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field